Metabolic Engineering of Fatty Acid Biosynthesis in Plants

2002 ◽  
Vol 4 (1) ◽  
pp. 12-21 ◽  
Author(s):  
Jay J. Thelen ◽  
John B. Ohlrogge
2015 ◽  
Vol 11 (1) ◽  
pp. 38-59 ◽  
Author(s):  
Joris Beld ◽  
D. John Lee ◽  
Michael D. Burkart

Fatty acids are primary metabolites synthesized by complex, elegant, and essential biosynthetic machinery.


2007 ◽  
Vol 1 (4) ◽  
pp. 185-197 ◽  
Author(s):  
Saheli Sinha ◽  
Jyoti K. Jha ◽  
Mrinal K. Maiti ◽  
Asitava Basu ◽  
Ujjal K. Mukhopadhyay ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Huhu Liu ◽  
Yulan Song ◽  
Xiao Fan ◽  
Chong Wang ◽  
Xiangyang Lu ◽  
...  

The microbial fermentation process has been used as an alternative pathway to the production of value-added natural products. Of the microorganisms, Yarrowia lipolytica, as an oleaginous platform, is able to produce fatty acid-derived biofuels and biochemicals. Nowadays, there are growing progresses on the production of value-added fatty acid-based bioproducts in Y. lipolytica. However, there are fewer reviews performing the metabolic engineering strategies and summarizing the current production of fatty acid-based bioproducts in Y. lipolytica. To this end, we briefly provide the fatty acid metabolism, including fatty acid biosynthesis, transportation, and degradation. Then, we introduce the various metabolic engineering strategies for increasing bioproduct accumulation in Y. lipolytica. Further, the advanced progress in the production of fatty acid-based bioproducts by Y. lipolytica, including nutraceuticals, biofuels, and biochemicals, is summarized. This review will provide attractive thoughts for researchers working in the field of Y. lipolytica.


1991 ◽  
Vol 81 (2) ◽  
pp. 251-255
Author(s):  
Manfred Focke ◽  
Andrea Feld ◽  
Hartmut K. Lichtenthaler

Author(s):  
L. K. Dahiwade ◽  
S. R. Rochlani ◽  
P. B. Choudhari ◽  
R. P. Dhavale ◽  
H. N. Moreira

Background: Mycobacterium tuberculosis is a causative organism of tuberculosis, which is most deadly disease after cancer in a current decade. The development of multidrug and broadly drug- resistant strains making the tuberculosis problem more and more critical. In last 40 years, only one molecule is added to the treatment regimen. Generally, drug design and development programs are targeted proteins whose function is known to be essential to the bacterial cell. Objectives: Reported here are the development of 'S', 'N’ heterocycles as antimycobacterials targeting fatty acid biosynthesis. Material and Methods: In the present communication, rational development of anti-mycobacterial agent's targeting fatty acid biosynthesis has been done by integrating the pocket modelling and virtual analysis. Results: The identified potential 33 lead compounds were synthesized, characterized by physicochemical and spectroscopic methods like IR, NMR spectroscopy and further screened for antimycobacterial activity using isoniazid as standard. All the designed compounds have shown profound antimycobacterial activity. Conclusion: In this present communication, we found that 3c, 3f, 3l and 4k molecules had expressive desirable biological activity and specific interactions with fatty acids. Further optimization of these leads is necessary for the development of potential antimycobacterial drug candidate having less side effects.


Sign in / Sign up

Export Citation Format

Share Document